J. Saxton

发表

The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis.

J. Becker, O. Lopez, F. Boller, 1994, Archives of neurology.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Jeffrey A. James, S. DeKosky, P. Houck, 2008, Archives of neurology.

Sex differences in brain aging: a quantitative magnetic resonance imaging study.

G. Ratcliff, R. Bryan, C. Coffey, 1998, Archives of neurology.

Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve

Bedda L. Rosario, Jeffrey A. James, S. DeKosky, 2009, The Journal of Neuroscience.

Amyloid imaging in mild cognitive impairment subtypes

Jeffrey A. James, O. Lopez, S. DeKosky, 2009, Annals of neurology.

Clinical features and assessment of severe dementia. A review.

L. Hugonot-Diener, F. Boller, J. Saxton, 2002, European journal of neurology.

Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I

O L Lopez, J T Becker, S. Wisniewski, 2000, Neurology.

Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II

S. Wisniewski, J. Becker, S. DeKosky, 2000, Neurology.

Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia

O L Lopez, O. Lopez, S. DeKosky, 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities

W. Klunk, C. Mathis, J. Price, 2013, Neuropsychologia.

Objective measures of physical activity, white matter integrity and cognitive status in adults over age 80

S. Kritchevsky, A. Newman, C. Rosano, 2015, Behavioural Brain Research.

Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease

M. Sano, F. Schmitt, D. Galasko, 2000, Neurobiology of Aging.

Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes

C. Rosano, R. Boudreau, H. Aizenstein, 2015, Diabetes Care.

Methodological considerations in designing and implementing the harmonized diagnostic assessment of dementia for longitudinal aging study in India (LASI–DAD)

A. Toga, J. Jovicich, K. Langa, 2019, Biodemography and social biology.

Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease.

J. Becker, O. Lopez, H. Aizenstein, 2011, AIDS patient care and STDs.

Alteration of a Clinically Meaningful Outcome in the Natural History of Alzheimer's Disease by Cholinesterase Inhibition

J. Becker, O. Lopez, S. DeKosky, 2005, Journal of the American Geriatrics Society.

The association between congestive heart failure and cognitive performance in a primary care population of elderly adults: the Steel Valley Seniors Survey

M. Ganguli, J. Vander Bilt, J. Saxton, 2006, International Psychogeriatrics.

Measuring Physical Activity Using Accelerometry in a Community Sample with Dementia

Regina L. Leckie, J. Becker, O. Lopez, 2013, Journal of the American Geriatrics Society.

Comparison of criteria for diagnosing Alzheimer's disease in the United States and Europe.

F. Boller, J. Saxton, 1990, Advances in neurology.

RESPONSE LETTER TO DR. THOMAS FINUCANE

J. Becker, O. Lopez, S. DeKosky, 2005 .

P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

Keith A. Johnson, D. Pollen, A. Fischman, 2006, Alzheimer's & Dementia.

Cognitive domains and trajectories of functional independence in nondemented elderly persons.

H. Dodge, M. Ganguli, J. Saxton, 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial.

R. Hofbauer, J. Saxton, M. Woodward, 2012, Journal of Alzheimer's disease : JAD.

Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches

Lisa A. Weissfeld, Oscar L. Lopez, Howard Aizenstein, 2013, NeuroImage.

Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery.

F. Boller, J. Saxton, A. Swihart, 1990 .

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

J. Becker, O. Lopez, S. DeKosky, 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

A Brief Instrument to Assess Treatment Response in the Patient With Advanced Alzheimer Disease

F. Schmitt, J. Saxton, T. McRae, 2009, Alzheimer Disease and Associated Disorders.

Clinical features and assessment of severe dementia. A review 1

L. Hugonot-Diener, F. Boller, J. Saxton, 2002 .

Oscar L. Lopez, Cameron S. Carter, Lewis H. Kuller, 2005, Biological Psychiatry.

A New Measure of Caregiver Burden in Alzheimer’s Disease

J. Saxton, T. Wilcox, M. Erder, 2012, American journal of Alzheimer's disease and other dementias.

Reliability and Validity of the Severe Impairment Battery (SIB) in Korean Dementia Patients

J. Saxton, Doh-Kwan Kim, Inn-sook Ahn, 2006, Journal of Korean medical science.

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

S. Wisniewski, J. Becker, O. Lopez, 2002, Journal of neurology, neurosurgery, and psychiatry.

Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

K. Sink, O. Lopez, S. DeKosky, 2009, JAMA.

Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Lewis H Kuller, Oscar L Lopez, Linda P Fried, 2008, JAMA.

Randomized Controlled Trial for Prevention of Dementia : AGinkgo biloba

R. Kronmal, J. Williamson, L. Fried, 2008 .

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

John Robbins, Lewis H Kuller, Oscar L Lopez, 2006, Contemporary clinical trials.

Outcomes of mild cognitive impairment by definition: a population study.

Ronald C Petersen, David A Loewenstein, Mary Ganguli, 2011, Archives of neurology.

Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease.

J. Becker, O. Lopez, S. DeKosky, 2003, The Journal of neuropsychiatry and clinical neurosciences.

Severe impairment battery. A neuropsychological test for severely demented patients.

F. Boller, J. Saxton, M. Panisset, 1994, Archives of neurology.

Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype.

O. Lopez, S. DeKosky, D. Kaufer, 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Alcohol, Dementia, and Alzheimer's Disease: Comparison of Neuropsychological Profiles

M. Butters, J. Saxton, C. Munro, 2000, Journal of geriatric psychiatry and neurology.

Speed and Capacity of Language Processing Test: Normative Data From an Older American Community-Dwelling Sample

A Baddeley, G Ratcliff, A. Baddeley, 2001, Applied neuropsychology.

Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment

S. Wisniewski, J. Becker, O. Lopez, 2003, Annals of neurology.

Amyloid Imaging with PET in Alzheimer’s Disease, Mild Cognitive Impairment, and Clinically Unimpaired Subjects

S. DeKosky, W. Klunk, C. Mathis, 2009 .

Amyloid imaging in dementias with atypical presentation

S. DeKosky, W. Klunk, C. Mathis, 2012, Alzheimer's & Dementia.

Association between Cognitive Decline in Older Adults and Use of Primary Care Physician Services in Pennsylvania

Nicole R. Fowler, D. Landsittel, B. Snitz, 2012, Journal of primary care & community health.

Why we need two cutoffs for amyloid imaging: Early versus Alzheimer's-like amyloid-positivity

Howard Aizenstein, Lisa Weissfeld, Chester Mathis, 2012, Alzheimer's & Dementia.

Effects of memantine treatment on language abilities and functional communication: A review of data

O. Lopez, R. Hofbauer, J. Saxton, 2014 .

Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer’s disease

M. Weiner, C. Sadowsky, R. Hofbauer, 2011, Alzheimer's & Dementia.

Cognitive Test Performance and Presence of Subclinical Cardiovascular Disease in the Cardiovascular Health Study

G. Ratcliff, L. Fried, L. Kuller, 2000, Neuroepidemiology.

Cognitive Assessment of Older Primary Care Patients with and Without Memory Complaints

M. Ganguli, J. Saxton, C. Chang, 2007, Journal of General Internal Medicine.

A comparison of measures of memory impairment for use in the diagnosis of Alzheimer's disease.

J. Becker, J. Saxton, F. Huff, 1989 .

The Relation of White Matter Hyperintensities to Cognitive Performance in the Normal Old: Education Matters

S. DeKosky, P. Houck, R. Nebes, 2006, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Alcohol consumption and cognitive function in late life

H. Dodge, M. Ganguli, J. Saxton, 2005, Neurology.

Temporal Stability of Receptiveness to Clinical Research on Alzheimer Disease

J. Saxton, J. Lingler, Daniel Rubin, 2010, Alzheimer disease and associated disorders.

In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects

Lewis H Kuller, Oscar L Lopez, Bedda L. Rosario, 2013, Annals of neurology.

Factors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey.

Shu-Ya Lu, Mary Ganguli, M. Ganguli, 2008, The American journal of geriatric pharmacotherapy.

The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.

B. Pollock, S. Perera, R. Nebes, 2012, The American journal of geriatric pharmacotherapy.

Alcohol dementia: "cortical" or "subcortical" dementia?

M. Butters, J. Saxton, C. Munro, 2001, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Prevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project.

B. Snitz, M. Ganguli, J. Saxton, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study

O. Lopez, S. DeKosky, B. Snitz, 2009, Aging & mental health.

Reliability and validity of a short form of the Severe Impairment Battery in Korean Alzheimer's disease patients

J. Saxton, Doh-Kwan Kim, Inn-sook Ahn, 2007, International journal of geriatric psychiatry.

High medical co-morbidity and family history of dementia is associated with lower cognitive function in older patients.

B. Snitz, J. Saxton, L. Morrow, 2009, Family practice.

Subjective memory complaints and concurrent memory performance in older patients of primary care providers

B. Snitz, J. Saxton, L. Morrow, 2008, Journal of the International Neuropsychological Society.

Preclinical Alzheimer disease

G. Ratcliff, L. Fried, L. Kuller, 2004, Neurology.

Evaluation of an 8‐item Severe Impairment Battery (SIB‐8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study

S. Ferris, J. Saxton, J. Mackell, 2013, International journal of clinical practice.

Detection and Management of Cognitive Impairment in Primary Care: The Steel Valley Seniors Survey

Benoit Mulsant, Hiroko H Dodge, Mary Ganguli, 2004, Journal of the American Geriatrics Society.

Computer Assessment of Mild Cognitive Impairment

Amy Eschman, J. Luther, J. Saxton, 2009, Postgraduate medicine.

Trajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults

S. Kritchevsky, C. Rosano, R. Boudreau, 2015, Neurobiology of Aging.

The relation of White Matter Hyperintensities to implicit learning in healthy older adults

S. DeKosky, R. Nebes, H. Aizenstein, 2002, International journal of geriatric psychiatry.

Age and education effects and norms on a cognitive test battery from a population-based cohort: The Monongahela–Youghiogheny Healthy Aging Team

B. Snitz, M. Ganguli, J. Saxton, 2010, Aging & mental health.

Effects of age, gender, education and race on two tests of language ability in community-based older adults

Sujuan Gao, Mary Ganguli, Frederick W Unverzagt, 2009, International Psychogeriatrics.

Normal Rates of Forgetting of Verbal and Non-Verbal Material in Alzheimer's Disease

J. Becker, F. Boller, J. Saxton, 1987, Cortex.

Age of Childhood Onset in Type 1 Diabetes and Functional Brain Connectivity in Midlife

C. Rosano, H. Aizenstein, J. Saxton, 2015, Psychosomatic medicine.

Cognitive correlates of human brain aging: a quantitative magnetic resonance imaging investigation.

G Ratcliff, R N Bryan, G. Ratcliff, 2001, The Journal of neuropsychiatry and clinical neurosciences.

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B

James T. Becker, William E. Klunk, Chester A. Mathis, 2008, Journal of Neuroscience Methods.

Normative Data on the Boston Naming Test and Two Equivalent 30-Item Short Forms

G Ratcliff, J T Becker, J. Becker, 2000, The Clinical neuropsychologist.

Longitudinal increase in the volume of white matter hyperintensities in late‐onset depression

S. DeKosky, R. Nebes, C. Meltzer, 2002, International journal of geriatric psychiatry.

Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia

L. Kuller, O. Lopez, S. DeKosky, 2013, Neurology.

Measurement and Structure of Cognition in the Longitudinal Aging Study in India—Diagnostic Assessment of Dementia

Erik Meijer, A. Gross, J. Saxton, 2020, Journal of the American Geriatrics Society.

Cognitive testing in older primary care patients: A cluster-randomized trial

Nicole R. Fowler, Beth Snitz, B. Snitz, 2015, Alzheimer's & dementia.

Response to Comment on Nunley et al. Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes. Diabetes Care 2015;38:1768–1776

C. Rosano, J. Saxton, T. Orchard, 2016, Diabetes Care.

Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.

B. Pollock, P. Houck, R. Nebes, 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Development of a short form of the Severe Impairment Battery.

B. Pollock, S. DeKosky, P. Mecocci, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.

J. Becker, C. Reynolds, O. Lopez, 2013, The American journal of psychiatry.

Cognitive test performance predicts change in functional status at the population level: The MYHAT Project

David A Loewenstein, Mary Ganguli, B. Snitz, 2010, Journal of the International Neuropsychological Society.

Genetic Risk Score Predicts Late-Life Cognitive Impairment

Nicole R. Fowler, B. Snitz, J. Saxton, 2015, Journal of aging research.

A pilot study of the effects of internet-based cognitive stimulation on neuropsychological function in HIV disease

J. Becker, O. Lopez, H. Aizenstein, 2012, Disability and rehabilitation.

Cross-cultural comparisons of the Mini-mental State Examination between Japanese and U.S. cohorts

Hiroshi Ishii, Satoshi Yamaguchi, Kenichi Meguro, 2009, International Psychogeriatrics.

Neuropsychological assessment of the severely impaired elderly patient.

J. Saxton, A. Swihart, A A Swihart, 1989, Clinics in geriatric medicine.

Outcomes of Mild Cognitive Impairment by Definition

R. Petersen, B. Snitz, M. Ganguli, 2016 .

Memory Impairment in Elderly Individuals With a Mildly Elevated Serum TSH: The Role of Processing Resources, Depression and Cerebrovascular Disease

S. DeKosky, R. Nebes, C. Meltzer, 2002 .

In vivo amyloid deposition and neuropathological findings after humanized amyloid β-specific monoclonal antibodies therapy in a patient with Alzheimer's disease

J. Becker, O. Lopez, S. DeKosky, 2009, Alzheimer's & Dementia.

Exploring the Reasons Urban and Rural-Dwelling Older Adults Participate in Memory Research

J. Saxton, L. Morrow, J. Lingler, 2011, American journal of Alzheimer's disease and other dementias.

A novel approach to assessing memory at the population level: vulnerability to semantic interference

B. Snitz, M. Ganguli, J. Vander Bilt, 2010, International Psychogeriatrics.

Diagnostic Assessment & Prognosis Cognitive testing in older primary care patients: A cluster-randomized trial

Nicole R. Fowler, B. Snitz, J. Saxton, 2015 .

Cognitive Status and Physical Function in Older African Americans

S. Albert, J. Saxton, L. Morrow, 2008, Journal of the American Geriatrics Society.

Functional neuroimaging indicators of successful executive control in the oldest old

C. Rosano, H. Aizenstein, J. Cochran, 2005, NeuroImage.

Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease

F. Schmitt, S. Ferris, J. Saxton, 2011, Alzheimer's Research & Therapy.

The Severe Impairment Battery: Concurrent Validity and the Assessment of Longitudinal Change in Alzheimer's Disease

L. Schneider, L. Thal, F. Schmitt, 1997, Alzheimer disease and associated disorders.

The neuropsychological consequences of abstinence among older alcoholics: a cross-sectional study.

M. Butters, J. Saxton, C. Munro, 2000, Alcoholism, clinical and experimental research.

Long-term changes in retinal vascular diameter and cognitive impairment in type 1 diabetes

R. Klein, C. Rosano, H. Aizenstein, 2018, Diabetes & vascular disease research.

Neuropsychological assessment of the severely impaired elderly patient: Validation of the Italian short version of the Severe Impairment Battery (SIB)

M. Pippi, P. Mecocci, J. Saxton, 1999, Aging.

Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression.

C. Reynolds, S. DeKosky, P. Houck, 2001, The American journal of psychiatry.

The Alzheimer's Disease Centers' Neuropsychological Database Initiative: A Resource for Alzheimer's Disease Prevention Trials

L. Thal, J. Brandt, D. Salmon, 2002 .

Relation of education to brain size in normal aging

G. Ratcliff, R. Bryan, C. Coffey, 1999, Neurology.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Jeffrey A. James, S. DeKosky, P. Houck, 2008, Archives of neurology.

Amyloid imaging in mild cognitive impairment subtypes

Jeffrey A. James, O. Lopez, S. DeKosky, 2009, Annals of neurology.

Computer Assessment of Mild Cognitive Impairment

J. Luther, J. Saxton, L. Morrow, 2009, Postgraduate medicine.

Subjective memory complaints and concurrent memory performance in older patients of primary care providers

B. Snitz, J. Saxton, L. Morrow, 2008, Journal of the International Neuropsychological Society.

Patterns of change in the treatment of psychiatric symptoms in patients with probable Alzheimer's disease from 1983 to 2000.

J. Becker, O. Lopez, S. DeKosky, 2003, The Journal of neuropsychiatry and clinical neurosciences.

Severe Impairment Battery: A Potential Measure for AD Clinical Trials

L. Schneider, L. Thal, C. Clark, 1997 .

Alcohol consumption and cognitive function in late life

H. Dodge, M. Ganguli, J. Saxton, 2005, Neurology.

Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

K. Sink, O. Lopez, S. DeKosky, 2009, JAMA.

DRUG DISCOVERY: CLINICAL TRIALS O3-04-01 SAFETY AND EFFICACY OF TARENFLURBIL IN SUBJECTS WITH MILD ALZHEIMER’S DISEASE: RESULTS FROM AN 18-MONTH MULTI-CENTER PHASE 3 TRIAL

J. Saxton, K. Zavitz, L. Dunn, 2008 .